Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

22
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
22
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Takotsubo - The great pretender.

International journal of cardiology·2025
Same author

Time to Tweak the Definition of Type 2 Myocardial Infarction.

The American journal of cardiology·2024
Same author

Artificial Intelligence and the Doctor-Patient Relationship.

The American journal of medicine·2024
Same author

In Search of Coronary Thrombosis as the Cause of Myocardial Infarction: Unraveling a 20th-Century Mystery.

The American journal of medicine·2022
Same author

New Precordial T Wave Inversions in Hospitalized Patients.

The American journal of medicine·2021
Same author

Spontaneous Coronary Artery Dissection in Levo-Transposition of the Great Arteries.

JACC. Case reports·2021

Related Experiment Video

Updated: Jul 18, 2025

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

7.4K

Identifying and Treating Vulnerable Atherosclerotic Plaques.

John A Ambrose1, Avinash V Sharma1

  • 1Division of Cardiology, Department of Medicine, UCSF Fresno Medical Education Program, Fresno, California.

The American Journal of Cardiology
|August 23, 2023
PubMed
Summary

Identifying vulnerable plaques causing acute coronary syndromes is key. New imaging techniques help detect these nonobstructive, high-risk plaques for preventive strategies against myocardial infarction.

Keywords:
atherosclerosisplaque erosionthin-capped fibroatheromavulnerable plaque

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.9K
Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
08:13

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

Published on: March 22, 2016

10.6K

Related Experiment Videos

Last Updated: Jul 18, 2025

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

7.4K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.9K
Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
08:13

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

Published on: March 22, 2016

10.6K

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Acute coronary syndromes often result from coronary thrombosis on disrupted or eroded atherosclerotic plaques.
  • These vulnerable plaques, typically nonobstructive, are the primary cause of myocardial infarction and sudden cardiac death.
  • Traditional cardiology focused on obstructive lesions, overlooking vulnerable plaques.

Purpose of the Study:

  • To explore the identification and management of vulnerable, thrombus-prone plaques.
  • To discuss novel preventive strategies targeting asymptomatic high-risk plaques.
  • To review noninvasive and interventional approaches for managing these lesions.

Main Methods:

  • Utilizing computed tomographic angiography (CTA) to identify vulnerable plaques.
  • Employing intravascular imaging during invasive coronary angiography for plaque detection.
  • Analyzing noninvasive techniques and systemic therapies for patient management.

Main Results:

  • CTA and intravascular imaging can identify a majority of vulnerable plaques before symptom onset.
  • These imaging modalities enable the detection of nonobstructive, yet high-risk, plaques.
  • New preventive strategies can be developed based on early plaque identification.

Conclusions:

  • Vulnerable plaque identification is crucial for preventing thrombotic events like myocardial infarction.
  • Noninvasive and systemic therapies offer avenues for managing patients with these lesions.
  • A novel interventional paradigm may emerge for treating thrombus-prone plaques.